Jennifer Riley
Fortuna: 733 582 $ al 30/06/2026
Fortuna: 733 582 $ al 30/06/2026
Jennifer Riley is the founder of Northbrook Consulting LLC, founded in 2014.
Ms. Riley is currently Chief Strategy Officer at Avalo Therapeutics, Inc., starting in 2025.
Formerly, Ms. Riley was Vice President-Program Leadership & Management at Biogen, Inc. Ms. Riley completed undergraduate studies at the University of California San Diego and graduate studies at Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AVALO THERAPEUTICS INC 0,08 % | 10/06/2026 | 39.696 ( 0,08 % ) | 733 582 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.